Abdominal fat in particular is considered dangerous. One reason for this is that obesity leads to a remodelling of the blood vessels, which promotes inflammation and functional disorders.

Discover CBL-514, a groundbreaking injection for targeted fat loss, offering a non-surgical alternative to liposuction with promising results.

Caliway has completed the End-of-Phase 2 (EOP2) meeting with the U.S. FDA for CBL-514, the world's first investigational drug for large-area subcutaneous fat reduction developed under the 505(b)(1 ...

Among the highlights, new data were presented demonstrating six-month efficacy of FluidForm’s FRESH 3D bioprinted human islet subcutaneous scaffolds to restore normoglycemia in SCID Beige mice.